相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype
Maximilian Boesch et al.
STEM CELLS INTERNATIONAL (2016)
VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients
Ah-Young Kwon et al.
STEM CELLS AND DEVELOPMENT (2015)
Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients
Xin Chen et al.
ONCOLOGY LETTERS (2015)
Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics
Maximilian Boesch et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Ovarian stem cells: From basic to clinical applications
Ozlem Bingol Ozakpinar et al.
WORLD JOURNAL OF STEM CELLS (2015)
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm
Kenneth Garson et al.
REPRODUCTION (2015)
Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway
B. Tan et al.
CANCER GENE THERAPY (2014)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population
Rachel Eyre et al.
TUMOR BIOLOGY (2014)
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Maximilian Boesch et al.
ONCOTARGET (2014)
Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ
YunQing Jiang et al.
BIOMARKER RESEARCH (2014)
DyeCycle violet used for side population detection is a substrate of P-glycoprotein
Maximilian Boesch et al.
CYTOMETRY PART A (2012)
2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference
Gavin C. E. Stuart et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Host Deficiency in Vav2/3 Guanine Nucleotide Exchange Factors Impairs Tumor Growth, Survival, and Angiogenesis In vivo
Dana M. Brantley-Sieders et al.
MOLECULAR CANCER RESEARCH (2009)
Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer
Kiwon Lee et al.
BMC CANCER (2008)
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer
Xuesong Ouyang et al.
CANCER RESEARCH (2008)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma
Stephen Y. Lai et al.
ORAL ONCOLOGY (2008)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Clinical relevance of E2F family members in ovarian cancer - An evaluation in a training set of 77 patients
Daniel Reimer et al.
CLINICAL CANCER RESEARCH (2007)
Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-γ and EGF
Daniel Reimer et al.
CANCER BIOLOGY & THERAPY (2006)
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer:: Evidence for a crucial p53-p73 cross-talk in vivo
N Concin et al.
CLINICAL CANCER RESEARCH (2005)
Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers
C Sakakura et al.
CLINICAL CANCER RESEARCH (2005)
Cancer cell line identification by short tandem repeat profiling: power and limitations
W Parson et al.
FASEB JOURNAL (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation
LY Zeng et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton
A Hall et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2000)
Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors
T Trenkle et al.
GENE (2000)
Regulatory and signaling properties of the Vav family
XR Bustelo
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
